Hyloris Pharmaceuticals
Belgium - LiègePharmaceutical
Focus: Hyloris Pharmaceuticals is a Belgian specialty pharmaceutical company focused on reformulating existing therapies to improve clinical outcomes. The company operates at mid-cap scale with 51-200 employees and is publicly traded.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0
About Hyloris Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Hyloris Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Tranexamic acid
Bleeding From TeethClinical Trials (1)
NCT06143787Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
Phase 3Help build intelligence for Hyloris Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.